The design of novel xylo-like nucleoside analogues bearing a C3' all-carbon quaternary center and a C2'-hydroxy substituent is described. Synthesis of this scaffold makes use of highly diastereoselective transformations on acyclic substrates. Central to the approach is formation of a 2,4-syn cyanohydrin from cyanide addition onto an aldehyde through a proposed seven-membered ring chelate using a bidentate Lewis acid. In addition, a highly diastereoselective Mukaiyama aldol reaction, an intramolecular radical atom cyclization, and thioaminal formation are used to generate this novel molecule. A series of related nucleoside analogues are being tested as antiviral and anticancer agents.
Introduction
The implication of endogenous nucleosides and nucleotides in numerous biological pathways has, not surprisingly, inspired the development of various analogues as inhibitors of tumor growth and viral replication. 1, 2, 3 Exploring the biological profiles of novel nucleoside analogues remains crucial, as shown by the recent approval of highly efficient antiviral drugs. 4 We have initiated the syntheses of novel nucleoside analogues possessing an all-carbon quaternary stereogenic center at C3'. [5] [6] [7] It is proposed that this chiral center could enhance target specificity in addition to providing opportunities for the incorporation of different pharmacophores. As illustrated in Figure 1 , the hydroxymethyl substituent at C3' can have either a xylo/lyxo-(β-face) or ribo/arabino-(α-face) like orientation. The syntheses of C2'-fluoro analogues in which the hydroxymethyl substituent is located on the α-face (ribo-like scaffolds) has been previously reported by our group. 8 Herein, we describe the synthesis of xylo-like analogues with a C2'-hydroxy group. Incorporation of a C3'-hydroxymethyl substituent with a β-orientation is a feature of apio-nucleosides, a class of analogues in which the hydroxymethyl normally found at C4' is shifted to C3'. [9] [10] [11] Presently, our scaffolds are being tested for their antiviral and anticancer properties; however, this novel xylo-like scaffold may also show potential in the design of new fungicides 12 and insecticides, 13 as antimicrobial agents 14 and acetylcholinesterase inhibitors 15 all of which contain a xylo-furanoside core. To construct our novel scaffold (1), a series of diastereoselective acyclic transformations were developed (Scheme 1). Using our two-step acyclic approach for the synthesis of nucleoside analogues, 1',2'-trans furanoside 2, was formed from a kinetically controlled intramolecular cyclization of chiral thioaminal 3. This 1,2-syn thioaminal resulted from diastereoselective nucleobase addition onto dithioacetal 4.
A bidentate Lewis acid could generate different reactive chelate intermediates. Chelation between the β-hydroxy group and the aldehyde is expected to give preference for the undesired 2,4-anti relationship through TS D, which avoids steric clash between the incoming nucleophile and the -CH2OBn found in TS E (2,4-syn predictive transition state). However, the presence of the α-quaternary center could decrease the energy difference between TS D and TS E, the former having two gauche interactions between the substituents of the α-and β-stereogenic centers. Formation of a seven-membered ring intermediate (TS F and TS G) between the primary oxygen and the aldehyde could allow more flexibility for chelate formation and alleviate steric interactions between the incoming nucleophile and the quaternary center. Formation of the desired 2,4-syn cyanohydrin (TS G) in which nucleophilic attack occurs on the bottom face should be favored to avoid eclipsing interactions between the incoming nucleophile and the axial methyl of the quaternary center in TS G or with the β-hydroxy group in TS F.
To prevent potential competition between six-and seven-membered ring chelates, a bulky TBS group was incorporated onto the β-hydroxy of aldehyde 6. Precomplexation of aldehyde 6 with an excess of MgBr2·OEt2 24 was followed by addition of the cyanide source (TMSCN) at -15 o C (Scheme 5). Cyanohydrin 5 was formed in an 8:1 ratio in favor of the 2,4 syn isomer in excellent yield (83% over two steps). It is noteworthy that the reaction of TMSCN and the aldehyde alone in DCM resulted in recuperation of the starting material, thus highlighting the need for a source of Lewis acid. Cyanide addition did occur in the presence of a Lewis base (NEt3 or NH(i-Pr)2) to furnish OTMS protected cyanohydrins (results not shown), albeit with low diastereoselectivity. 26 These observations are in accordance with precedent examples demonstrating that a Lewis acidic or basic species is needed to activate the TMSCN through formation of a pentacoordinate siliconate ion. 27, 28 Scheme 5. Synthesis of 2,4-syn cyanohydrin.
To validate our initial hypotheses for 2,4-syn selectivity, a model study was undertaken at 0 o C ( Table 1) . As can be seen in entry 1, a 6:1 ratio in favor of the syn cyanohydrin was obtained at this temperature. When the reaction was performed with a monodentate Lewis acid, BF3 . OEt2, an expected low diastereoselectivity of 1.5:1 was observed in favor of the 2,4-syn product (entry 2). Interestingly, when the TBS β-hydroxy protecting group was replaced by a benzyl or p-methoxybenzyl group, (aldehydes 17 and 19), preference for the 2,4-syn cyanohydrin was maintained (entries 3 and 4) with MgBr2·OEt2, even though competing TS D could be at play. With aldehyde 21, bearing a free β-hydroxy group (entry 5), a reversal of selectivity in favor of the 2,4-anti product was indeed noted suggesting reaction through TS D.
Suppressing the possibility of creating a seven-membered ring chelate by replacing the primary benzyl protecting group with a bulky silyl ether, as in aldehyde 23, abolished the diastereoselection noted before (1.5:1, entry 6). Similarly, when the benzyl ether was replaced by its carbon equivalent as in 25, a decrease in selectivity was observed (2.5:1, entry 7). To ensure that this loss of selectivity was not the result of having an α-gem-dimethyl instead of the stereogenic center, we prepared 27 and observed a high syn preference (11:1 entry 8 versus 6:1 entry 1) which suggests a greater interaction between the incoming nucleophile and olefin in TS G. Taken together, these results support the intermediacy of a 7-membered ring chelate (TS G) [29] [30] [31] in inducing 2,4-syn diastereoselectivity for cyanohydrin formation in the presence of MgBr2·OEt2.
Interestingly, with the use of a titanium Lewis acid (Table 1 , entries 9-13), formation of the 2,4-anti cyanohydrin could be favored. When aldehyde 19 bearing a β-PMB was reacted with 1.1 equivalents of TiCl3(OiPr), a 1:1 ratio of syn and anti cyanohydrins were formed (entry 9) in which the β-PMB was cleaved. Upon increasing the equivalents of TiCl3(OiPr) to 2.5 (entries 10 and 11) a 1:6 ratio was obtained in favor of the 2,4-anti diol 22b. Not surprisingly, with a β-OTBS, preference for the 2,4-syn cyanohydrin 5a was maintained (3:1 ratio, entry 12), favoring cyanation through 7-membered chelate TS G or monodentate activation. NMR Studies. To help elucidate the preference for 2,4-anti cyanohydrin formation with aldehydes 19 (β-OPMB) and 21 (β-OH) in the presence of 2.5 equivalents of TiCl3(OiPr) (entries 10 and 11), low temperature 13 C NMR spectra of the complexed aldehydes were acquired in CD2Cl2 (Figure 2 ). The first observation made was that both aldehydes resulted in similar 13 C spectra upon addition of 1.1 equivalents of TiCl3(OiPr), which indicates that the β-PMB of aldehyde 19 is cleaved before addition of the nucleophile. 32 Complex spectra (not shown) were obtained with three new peaks in the carbonyl region. It is likely that these correspond to different intermediates that react unselectively to give mixtures of diastereomers (Table 1, entry 9 ). However, in the presence of 2.5 equivalents of TiCl3(OiPr) (Figure 2 , upper spectrum) there is clearly only one complexed carbonyl species with a significant downfield (11.5 ppm) signal. In addition, the carbons corresponding to C3, C4 and C5 are also all shifted downfield, which supports their involvement in complex formation. Although an X-ray structure of this titanium complex has yet to be determined, the above preliminary 13 C NMR spectra support formation of a complex as in intermediate E (Scheme 6). Formation of this intermediate is supported by Gau's studies of titanium complexes, 33 where he noted the prevalence of hexacoordinated species. In addition, these studies suggested that the binding ability of various chemical entities to titanium was -OiPr > Cl -> THF > Et2O > PhCHO > µ-Cl -> RCO2M. Based on the 13 C NMR data, the first step in the complexation of TiCl3(OiPr) with aldehydes 19 and 21 is formation of a covalent bond between the oxygen at C3 and the titanium resulting in intermediate B (Scheme 6). Following Gau's study, the second oxygen to coordinate would be the oxygen at C4 resulting in intermediate C in which the carbonyl is uncoordinated.
Although carbonyl activation is not necessary for cyanation to occur, 13 C NMR studies indicate that it is indeed complexed with the titanium. Upon addition of a second equivalent of TiCl3(OiPr), intermediate D could be formed, but monodentate activation is not likely to provide high diastereoselectivities, as observed with 1.1 equivalents of TiCl3(OiPr) (Table 1, entry 9). Formation of intermediate E in which both titaniums are coordinated to the oxygen at C3 would be consistent with the need for 2.5 equivalents of TiCl3(OiPr) to reach higher levels of diastereoselectivity. Various titanium complexes were examined by density functional theory (DFT) calculations in Gaussian 09 (D.01) with tight SCF convergence 34 using the M062X 35 /6-31G* level of theory in DCM with the polarizable continuum model (PCM). 36 Intermediate E in which the isopropoxide ligands are located trans to the C1-aldehyde and C4-OBn group was of lowest energy. Through NBO analysis, a weak interaction was observed between the chloride ligand and the C4'-Ti thus both titanium centers exist as hexacoordinate species. Although, it is also possible to form a bicyclic [3.2.1]-type complex with 2.5 equivalents of TiCl3(OiPr), as previously proposed, 37 our preliminary 13 C NMR data is consistent with formation of intermediate E through initial displacement of a chloride ligand. Preferential attack of the cyanide opposite the β-alkyl chain in TS H would result in formation of the 2,4-anti cyanohydrin 22b. Interestingly, when aldehyde 17 bearing a β-OBn group was reacted in the presence of 2.5 equivalents of TiCl3(OiPr) (entry 13, Table 1 ), a 1:1 ratio of syn and anti cyanohydrins 18a,b was obtained. The presence of this benzyl protecting group results in a reaction pathway not involving intermediate E.
Investigation of this cyanation reaction has demonstrated that the choice of Lewis acid and β-protecting group are key to reach high levels of diastereoselectivity in favor of the 2,4-syn or 2,4-anti cyanohydrin allowing access to either the xylo-like (this manuscript) or the lyxo-like nucleoside analogues. In addition, this cyanation reaction highlights the potential for other stereoselective nucleophilic additions onto aldehydes possessing an α-stereogenic center for which there are few literature examples. 38, 39 Scheme 7. Acyclic approach for the synthesis of nucleoside analogues.
At this point in the strategy, we made use of our novel two-step acyclic approach for the synthesis of nucleoside analogues, 40 the mechanism of which has been examined in detail using DFT calculations. 8, 41 We have recently reported the use of this strategy with a C3-quaternary center and a fluoride at C2, 8 however, this is the first report of using this strategy with a thioaminal bearing a C2-hydroxy and a C3-quaternary center. An essential aspect of this strategy is the diastereoselective synthesis of a 1,2-syn thioaminal (29) from a dithioacetal (4) . Activation of this acyclic dithioacetal with iodine and addition of silylated nucleobase (thymine or uracil) provided the 1,2-syn thioaminals in excellent diastereoselectivity (only one isomer could be detected by 1 H NMR) and yield. Formation of the 1,2-syn thioaminal proceeds through a SN2-like mechanism in which the initially formed halothioether adopts a conformational preference orienting the C2-OTBS and the thioether moiety in close proximity to one another to maximize RC2 and HC2 sigma donation to the electron poor thiacarbenium intermediate in TS I. The presence of the counteranion (I -) stabilizes this transition state and prefers to be located on the opposite side of the incoming nucleobase. 8, 41 Selective removal of the less hindered C4-TBS protecting group provided the necessary thioaminals 30 and 31 in excellent yields. The next key step of our acyclic approach involves a stereospecific displacement of the activated sulfur of the thioaminal by the C4-hydroxy with inversion of configuration (O4'-C1 cyclization). This provided the D-1',2'-trans furanosides 32 (thymine, 71% yield) and 33 (uracil, 80% yield). Proof of structure for the nucleoside analogues was determined by 2D NOESY experiments (see supporting information). Transformation of the monosubstituted alkene of 32 and 33 into the desired primary alcohol was accomplished in five steps (Scheme 8). This monosubstituted alkene could serve as the starting point for a variety of chemical modifications to add heteroatoms and diverse functionalities. In this study, it was transformed into an hydroxymethyl group. doublets, m = multiplet, app = apparent), coupling constants (Hz), and integration. 13 C NMR spectra were recorded at room temperature using 100.6 (Varian VXR 400 NMR) or 126 MHz. The data are reported as follows: chemical shift in ppm referenced to residual solvent (CDCl3 δ 77.16 ppm). Infrared spectra were recorded on a FTIR ABB Bomen (MB series) or a Bruker Platinum ATR (Alpha II series) spectrophotometer from a thin film of purified product and signals are reported in cm -1 . Mass spectra were recorded through electrospray ionization (ESI) positive ion mode using a Thermo Fischer LTQ Orbitrap XL. A Q exactive mass analyzer was used for HRMS measurements and were done by the Plateforme de découvertes en protéomique at l'Institut de Recherches Cliniques de Montréal (IRCM). Optical rotations were measured at room temperature from the sodium D line (589 nm) using a PerkinElmer 343 polarimeter and CDCl3 as solvent unless otherwise noted and calculated using the formula: [α]D =(100)αobs/(ℓ·(c)), where c = (g of substrate/100 ml of solvent) and ℓ = 1 dm. The characterization of chemical structures from X-ray data has been done at the Université de Montréal X-ray diffraction laboratory. Proofs of structure can be found in the supporting information.
General Procedure A: Reduction of ester
To a solution of ester in dry CH2Cl2 (67 mL, 0.20 M) at -40 o C, DIBAL-H (3.0 equiv.) was added. The solution was stirred until the ester (1.0 equiv.) was all consumed (1h30 at -40 o C) as determined by TLC. MeOH was added at -40 o C until gas formation ceased. An aqueous solution of potassium sodium tartrate was added, and the reaction mixture was warmed to room temperature. The aqueous layer was extracted with Et2O (3x). The organic layers were combined, dried over MgSO4, filtered and concentrated in vacuo.
General Procedure B: Oxidation of alcohol
To a solution of oxalyl chloride (1.3 equiv.) in anhydrous CH2Cl2 (0.10 M) at -78 o C, dimethyl sulfoxide (2.3 equiv.) was added dropwise. The solution was stirred for 20 minutes at which point the alcohol (1.0 equiv.), as a 0.40 M solution in anhydrous CH2Cl2, was added followed by stirring at -78 o C for 1h. Triethylamine (5.0 equiv.) was added and the reaction mixture was warmed to room temperature over 45 minutes. An aqueous solution of NH4Cl was added and the aqueous layer was extracted with Et2O (3x). The organic layers were combined, dried over MgSO4, filtered and concentrated in vacuo.
General Procedure C: Cyanohydrin formation
To a solution of aldehyde (1.0 equiv.) in anhydrous CH2Cl2 (0.10 M) at 0 o C, the appropriate Lewis acid, MgBr2·OEt2 (5.0 equiv.), BF3·OEt2 (1.5 equiv.), or TiCl3(OiPr) (1.1 or 2.5 equiv.), was added. The reaction mixture was stirred 5 minutes for precomplexation. TMSCN (2.0 equiv.) was then added. The solution was stirred until the aldehyde was all consumed, 1h at 0 o C, as determined by TLC. An aqueous solution of NaHCO3 was added and the aqueous layer was extracted with Et2O (3x). The organic layers were combined, dried over MgSO4, filtered and concentrated in vacuo. TiCl3(OiPr) was prepared by mixing one equivalent of Ti(OiPr)4 with three equivalents of TiCl4 in DCM. 42 Preparation of silylated nucleobases. To a suspension of the nucleobase in HMDS (2.7 equiv.) under inert atmosphere, (NH4)2SO4 (0.10 equiv.) was added. The reaction mixture was refluxed until a clear solution was obtained (typically three hours). Upon cooling to room temperature, the solution was placed under high vacuum for approximately 1 hour to remove excess HMDS. A solution of the silylated nucleobase was made in dichloroethane. 7 (4.8 g, 16 mmol, 1.0 equiv.) in CH2Cl2 (40 mL, 0.40 M), imidazole (3.3 g, 48 mmol, 3.0 equiv.) was added in one portion. Upon complete dissolution of imidazole, chloro(dimethyl)vinylsilane (3.14 mL, 20.8 mmol, 1.30 equiv.) was added dropwise. The reaction was then warmed to room temperature and stirring continued for 16 hours at which point 1 H NMR showed complete conversion of starting material. The reaction mixture was quenched with water. The aqueous layer was extracted with CH2Cl2 (3 × 25 mL), the organic layers were combined, washed with brine, dried over MgSO4, filtered and concentrated in vacuo to afford the crude product as a dark yellow oil. Coevaporation with toluene (2x) and purification using a silica pad (Hexanes/Et2O, 30:70) provided 8a,b (3.2 g, 52% yield over 3 steps, 3,4-anti : 3,4-syn 10:1) as a light-yellow oil. The minor product from the aldol reaction (11a,b) could not be separated. (12) . To a solution of the α-bromo ester 8a,b (2.0 g, 5.2 mmol, 1.0 equiv.) in toluene (11 mL, 0.50 M) at 0 °C, BEt3 (5.2 mL, 1.0 M, 1.0 equiv.) was added with a syringe pump over 4 hours. After completion of the reaction, ethanolamine (0.90 mL, 16 mmol, 3.0 equiv.) was added. The mixture was stirred for 30 minutes before it was transferred to a plastic vial and treated with 3HF·NEt3 (1.3 mL, 7.9 mmol, 1.5 equiv.) at 0 °C. The mixture was stirred at room temperature overnight. The crude solution was transferred dropwise into a cold solution of saturated NaHCO3. The aqueous layer was extracted with Et2O (2x), the organic layers were combined, dried over MgSO4, filtered and concentrated in vacuo. The crude product (2,3-syn, dr >20:1) was purified by flash chromatography on silica gel (Hexanes/Et2O, 60:40) to give 12 (1.05 g, 82%) as a colorless oil. The minor 3,4-syn product from the Mukaiyama aldol (not characterized) could be separated. 12: Rf = 0.3 (Hexanes/EtOAc, 65:35); (13) . To a solution of secondary alcohol 12 (4.9 g, 20 mmol, 1.0 equiv.) in CH2Cl2 (25 mL, 0.80 M) at 0 o C pyridine (3.2 mL, 40 mmol, 2.0 equiv.) and TBSOTf (5.5 mL, 24 mmol, 1.2 equiv.) were added. The resulting mixture was stirred at room temperature for 16 hours before addition of Et2O/Hexanes (1:1, 25 mL) and saturated aqueous NH4Cl (30 mL). After stirring vigorously for 10 minutes, the layers were separated, and the aqueous layer extracted with Et2O/Hexanes (1:1, 2 x 30 mL). The organic fractions were combined and washed successively with 1N HCl (2 x 40 mL), water and brine, dried over MgSO4, filtered and concentrated in vacuo. The crude residue (7.2 g, 99% yield) was coevaporated with toluene (2 x 10 mL) and used directly in the next reaction. A solution of the crude ester (7.2 g, 20 mmol, 1.0 equiv.) in CH2Cl2 (40 mL, 0.50 M) was cooled to -40 o C (MeCN/dry ice bath) followed by addition of DIBAL-H (45 mL, 45 mmol, 2.2 equiv.) over 10 minutes. After stirring 90 minutes at -40 o C, a saturated solution of aqueous Rochelle salt (60 mL) was slowly added followed by saturated aqueous Na2CO3 (10 mL) and Et2O (40 mL). The biphasic mixture was warmed to room temperature and vigorously stirred until both phases were clear (about 2 hours). The aqueous layer was extracted with Et2O (2 × 40 mL) and the combined organic fractions were washed with saturated aqueous Na2CO3 followed by brine, dried over MgSO4, filtered and concentrated in vacuo to afford the crude primary alcohol as a colorless oil which was used directly in the next step. The crude primary alcohol (6.6 g, 20 mmol, 1.0 equiv.) was dissolved in CH2Cl2 (20 mL, 1.0 M) and pyridine (6.5 mL, 80 mmol, 4.0 equiv.) and DMAP (0.49 g, 4.0 mmol, 0.20 equiv.) were added. The resulting reaction mixture was cooled to 0 o C and benzoyl chloride (2.8 mL, 24 mmol, 1.2 equiv.) was added dropwise. The reaction mixture was slowly warmed to room temperature and stirred for 5 hours before being cooled to (14) . To a 0 o C solution of acetal 13 (5.2 g, 12 mmol, 1.0 equiv.) in EtOAc (120 mL, 0.10 M), periodic acid (4.1 g, 18 mmol, 1.5 equiv.) was added in one portion. The resulting heterogeneous mixture was stirred vigorously for 15 minutes at 0 o C and then at room temperature until complete conversion (typically 3-4 hours by TLC monitoring). The mixture was diluted with Et2O (100 mL) and slowly poured into cold saturated aqueous Na2S2O3 (75 mL) and saturated aqueous Na2CO3 (10 mL). After vigorously stirring 30 minutes, the aqueous layer was extracted with Et2O (1 × 50 mL) and the combined organic fractions were washed with brine, dried over MgSO4, filtered and concentrated in vacuo to afford the aldehyde (4.4 g, 100% yield, crude) which was used directly in the next step. 1 (15) . To a solution of primary alcohol 14 (3.7 g, 10 mmol, 1.0 equiv.) in cyclohexane/CH2Cl2 (2:1, 100 mL, 0.10 M) at 0 o C, benzyl 2,2,2-trichloroacetimidate (2.4 mL, 13 mmol, 1.3 equiv.) and trifluoromethanesulfonic acid (0.13 mL, 1.5 mL, 0.15 equiv.) were added. The resulting suspension was stirred for 16 hours at room temperature at which point NEt3 (0.7 mL, 5 mmol, 0.5 equiv.) was added and the volatiles removed in vacuo. Hexane was added, and the solids filtered over Celite. Purification by flash chromatography (Hexanes/Et2O) provided 15 as a colorless oil (3.8 g, 84%): Rf = 0.51 (Hexanes/EtOAc, 90:10); (6) . To a solution of primary alcohol S1 (0.84 g, 2.4 mmol, 1.0 equiv.) in CH2Cl2 (24 mL, 0.10 M), Dess-Martin periodinane (DMP, 1.1 g, 2.6 mmol, 1.1 equiv.) was added. The resulting suspension was stirred for 16 hours at room temperature before addition of saturated aqueous Na2S2O3 (20 mL). The biphasic mixture was vigorously stirred for 30 minutes. The aqueous layer was extracted with CH2Cl2 (1x20 mL), the combined organic fractions were washed with brine, dried over MgSO4, filtered and concentrated in vacuo. The crude aldehyde was purified by flash -)-(2R,3R)-3-{(S)-2-(Benzyloxy)-1-[(tert-butyldimethylsilyl)oxy]ethyl}-2-hydroxy-3-methylpent-4-enenitrile  (5a), and (2S,3R)-1-(benzyloxy)-2-[(tert-butyldimethylsilyl)oxy]-3-[(S)-cyano(hydroxy)methyl]-3-methylpent-4 -en-1-ylium (5b): A solution of aldehyde 6 (700 mg, 2.01 mmol, 1.00 equiv.) in CH2Cl2 (20 mL, 0.10 M) was cooled to -15 o C (NH4Cl/ice) before addition of MgBr2·OEt2 (2.6 g, 10 mmol, 5.0 equiv.) in one portion. After 10 minutes, TMSCN (0.50 mL, 4.0 mmol, 2.0 equiv.) was added dropwise and the resulting mixture was stirred 1 hour at -15 o C. The reaction was quenched with saturated aqueous NaHCO3 (20 mL) and the biphasic mixture warmed to room temperature. After stirring vigorously for 15 minutes, Et2O (20 mL) was added and the aqueous layer was extracted with Et2O (1 × 15 mL). The combined organic fractions were washed with brine, dried over MgSO4, filtered and concentrated in vacuo to afford the crude cyanohydrin which could be used directly for the next step. 1 H NMR analysis of the crude mixture showed an 8:1 mixture of stereoisomers. Data for the major 2,4-syn-cyanohydrin 5a ( with cyanohydrins 5a,b, 18a,b, 20a,b, 22a,b, 24a,b, 26a,b ±)-(R)-2-[(S)-2-(Benzyloxy)-1-(tert-butyldimethylsilyloxy)ethyl]-2-methylbut-3-en-1-ol (S1). Following General Procedure A and purification by flash chromatography using 10:90 EtOAc:Hex, racemic alcohol S1 (4.5 g, 95% yield) was obtained as a clear oil. 1 H NMR and 13 C NMR as reported above for enantiopure compound. (6) . Following General Procedure B and purification by flash chromatography using 20:80 EtOAc:Hex, racemic aldehyde 6 (4.4 g, 97% yield) was obtained as a clear oil. 1 H NMR and 13 C NMR as reported above for enantiopure compound.
Compounds 8a,b and 12 from Scheme 2 (-)-Methyl (2R,3R)-2-bromo-3-{[dimethyl(vinyl)silyl]oxy}-3-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-2-methylpropanoate (8a) and (+)-methyl (2S,3R)-2-bromo-3-{[dimethyl(vinyl)silyl]oxy}-3-((
R)-2,2-dimethyl-1,3-dioxolan- 4-yl)-2-methylpropanoate (8b). To a 0 o C solution of crude methyl (3R)-2-bromo-3-((R)-2,2-dimethyl-1,3- dioxolan-4-yl)-3-hydroxy-2-methylpropanoate
ppm). (-)-Methyl (S)-2-((S)-[(R)-2,2-dimethyl-1,3-dioxolan-4-yl)(hydroxy)methyl]-2-methylbut-3-enoate

(+)-(R)-2-[(S)-((tert-Butyldimethylsilyl)oxy]-[(R)-2,2-dimethyl-1,3-dioxolan-4-yl)methyl]-2-methylbut-3-en-1-yl benzoate
ppm). (+)-(R)-2-{(S)-1-[(tert-Butyldimethylsilyl)oxy]-2-hydroxyethyl}-2-methylbut-3-en-1-yl benzoate
ppm). (+)-(R)-2-{(S)-2-(Benzyloxy)-1-[(tert-butyldimethylsilyl)oxy]ethyl}-2-methylbut-3-en-1-yl benzoate
chromatography (Hexanes/EtOAc) to provide 6 as a colorless oil (700 mg, 84% yield): Rf = 0.59 (Hexanes/EtOAcaqueous layer was extracted with Et2O (3x). The organic layers were combined, dried over MgSO4, filtered and concentrated
(±)-(S)-2-[(S)-2-(Benzyloxy)-1-(tert-butyldimethylsilyloxy)ethyl]-2-methylbut-3-enal
(±)-(2R,3R)-3-[(S)-2-(Benzyloxy)-1-(tert-butyldimethylsilyloxy)ethyl]-2-hydroxy-3-methylpent-4-enenitrile (5a) and (±)-(2S,3R)-3-[(S)-2-(benzyloxy)-1-(tert-butyldimethylsilyloxy)ethyl]-2-hydroxy-3-methylpent-4-enenitrile (5b)
. Cyanohydrins 5a and 5b were prepared following General Procedure C. 1 H NMR spectroscopic analysis of the crude reaction indicated a 6:1 mixture of 2,4-syn and anti diastereomers ( (17 Purification by flash chromatography using 20:80 EtOAc:Hex provided protected ester S5 as a clear oil (2.09 g, 70% yield): Rƒ = 0.25 (20: ±)-(R)-2-[(S)-2-(Benzyloxy)-1-(4-methoxybenzyloxy)ethyl]-2-methylbut-3-en-1-ol (S6) (19 ±)-(S)-2-[(S)-2-(Benzyloxy)-1-hydroxyethyl]-2-methylbut-3-enal (21) . To a solution of racemic aldehyde 6 (0.14 g, 0.42 mmol. 1.0 equiv.) in dry THF (4.1 µL, 0.10 M) at 0 o C, HF-pyridine (0.84 mL, 0.84 mmol, 2.0 mL/mmol) was added. The solution was warmed to room temperature and stirred overnight. An aqueous solution of NaHCO3 was added and the aqueous layer was extracted with Et2O (3x). The organic layers were combined, dried with MgSO4, filtered and concentrated in vacuo. Purification by flash chromatography using 30:70 EtOAc:Hex provided aldehyde 21 as a clear oil (56.6 mg, 58% yield): Rƒ = 0.23 (30: ±)-(2R,3R)-3-[(S)-2-(Benzyloxy)-1-hydroxyethyl]-2-hydroxy-3-methylpent-4-enenitrile (22a) and (±)-(2S,3R)-3-((S)-2-(benzyloxy)-1-hydroxyethyl)-2-hydroxy-3-methylpent-4-enenitrile (22b) . Cyanohydrins 22a and 22b were prepared following General Procedure C. 1 H NMR spectroscopic analysis of the crude reaction indicated a 1:4 mixture of 2,4-syn and anti diastereomers ( Table 1, Methyl 2-((S)-2,2,3,3,9,9-hexamethyl-8,8-diphenyl-4,7-dioxa-3,8-disiladecan-5-yl)-2-methylbut-3 -enoate (S7). To a solution of (S)-methyl 2-((S)-2-((tert-butyldiphenylsilyl)oxy)-1-hydroxyethyl)-2-methylbut-3-enoate 22 2-((S)-2,2,3,3,9,9-Hexamethyl-8,8-diphenyl-4,7-dioxa-3,8-disiladecan-5-yl)-2-methylbut-3-en-1 2-((S)-2,2,3,3,9,9-hexamethyl-8,8-diphenyl-4,7-dioxa-3,8-disiladecan-5-yl)-2-methylbut-3 missing), 119.3, 79.8, 69.2, 42.7, 36.3, 33.6, 29.8, 26.1, 22.0, 19.0, 18.4, -3.7, -4 Methyl 4-(benzyloxy)-3-hydroxy-2,2-dimethylbutanoate (S12) . To a solution of crude 2-(benzyloxy)-acetaldehyde 44 (1.8 g, 12 mmol, 1.0 equiv.) in anhydrous CH2Cl2 (125 mL, 0.10 M) at -78 o C, TiCl4 (1.00 M, 13.8 mL, 13.8 mmol, 1.15 equiv.) and commercially available enoxysilane ((1-methoxy-2-methylprop-1-en-1-yl)oxy)trimethylsilane) (4.9 mL, 24 mmol, 2.0 equiv.) were added. The resulting solution was stirred until the aldehyde was completely consumed as indicated by TLC (generally 90 min). A saturated aqueous solution of NH4Cl was added and the aqueous layer was extracted with EtOAc (3×). The organic layers were combined, washed with brine, dried over MgSO4, filtered and concentrated in vacuo. Purification provided S12 (2.22 g, 73%) which has been previously reported in the literature. 45 (±)-(S)-Methyl 4-(benzyloxy)-3-(tert-butyldimethylsilyloxy)-2,2-dimethylbutanoate (S13). To a solution of alcohol S12 (2.2 g, 8.8 mmol, 1.0 equiv.) in anhydrous CH2Cl2 (87 mL, 0.10 M) at 0 o C, 2,6-lutidine (2.0 mL, 18 mmol, 2.0 equiv.) and TBSOTf (2.8 mL, 12 mmol, 1.4 equiv.) were added. The solution was stirred until the alcohol was all consumed (1h 30m). An aqueous solution of NH4Cl was added and the aqueous layer was extracted with Et2O (3×). The organic layers were combined, dried over MgSO4, filtered and concentrated in vacuo. Purification by flash chromatography using 5:95 EtOAc:Hex provided protected ester S13 as a clear oil (2.7 g, 85% yield): Rƒ = 0.32 (10: (2S,4S)-5-(benzyloxy)-4-(tert-butyldimethylsilyloxy)-2-hydroxy-3,3-dimethylpentanenitrile (28b) . Cyano-4 (60 mg, 0.10 mmol, 1.0 equiv.) in THF (0.50 mL, 0.20 M) at 0 o C, silylated thymine (0.50 M in DCE, 0.40 mL, 0.20 mmol, 2.0 equiv.) and iodine (51 mg, 0.20 mmol, 2.0 equiv.) were added. The resulting dark purple reaction mixture was stirred 16 hours at 0 o C before addition of saturated aqueous Na2S2O3 (2 mL) followed by addition of a few drops of 2N NaOH. The biphasic mixture was warmed to room temperature and stirred vigorously until a clear homogeneous biphasic mixture was obtained. The aqueous layer was extracted with Et2O (2 × 2 mL) and the combined organic fractions were washed with brine, dried over MgSO4, filtered and concentrated in vacuo. 1 ) and iodine (61 mg, 0.24 mmol, 2.0 equiv.) were added. The resulting dark purple reaction mixture was stirred 16 hours at 0 o C before addition of saturated aqueous Na2S2O3 (2 mL) followed by addition of a few drops of 2N NaOH. The biphasic mixture was warmed to room temperature and stirred vigorously until a clear homogeneous biphasic mixture was obtained. The aqueous layer was extracted with Et2O (2 × 2 mL) and the combined organic fractions were washed with brine, dried over MgSO4, filtered and concentrated in vacuo to afford the crude thioaminal which was used directly in the next step. 1 H NMR spectroscopic analysis of the unpurified product indicated the formation of only one diastereomer. To a solution of the crude thioaminal in CH2Cl2/MeOH (1:1, 6.0 mL, 0.020 M), TsOH·H2O (114 mg, 0.60 mmol, 5.0 equiv.) was added. The resulting mixture was warmed to 50 o C and stirred for 16 hours. The reaction mixture was cooled to room temperature
ppm). (±)-(S)-Methyl 2-[(S)-1,2-bis(benzyloxy)ethyl]-2-methylbut-3-enoate (S3). To a solution of (S)-methyl 2-[(S)
-
ppm). (±)-(R)-2-[(S)-1,2-Bis(benzyloxy)ethyl]-2-methylbut-3-en-1-ol (S4
ppm). (±)-(S)-2-[(S)-1,2-Bis(benzyloxy)ethyl]-2-methylbut-3-enal
ppm). (±)-(2R,3R)-3-[(S)-1,2-Bis(benzyloxy)ethyl]-2-hydroxy-3-methylpent-4-enenitrile (18a) and (±)-(2S,3R)-3-[(S)-1,2-bis(benzyloxy)ethyl]-2-hydroxy-3-methylpent-4-enenitrile (18b
ppm). (±)-(S)-Methyl 2 [(S)-2-(benzyloxy)-1-(4-methoxybenzyloxy)ethyl]-2-methylbut-3-enoate (S5). To a solution of (S)-methyl 2-[(S)
ppm). (±)-(S)-2-[(S)-2-(Benzyloxy)-1-(4-methoxybenzyloxy)ethyl]-2-methylbut-3-enal
